肾血管性高血压的影像学:最新进展
本文综述肾血管性高血压(RVH)由肾动脉狭窄(RAS)激活肾素-血管紧张素系统所致,RAS可源于内在性狭窄或外压性压迫。文章总结了RVH的诊断评估触发条件、各影像学方法(肾US、MRA、CTA、常规血管造影)的作用与选择,以及影像在排除其他继发性高血压病因和评估并发症中的价值,并概述了根据病因选择的药物与手术/介入治疗。
要点
- 肾US(多普勒为主)常用于RVH初始筛查,尤其肾功能减退时,可评估血流动力学显著的RAS(包括支架内)及肾实质。
- MRA是RVH评估的优良方法,通常在US后进行;肾功能减退患者可不用对比剂或用ferumoxytol,但2组钆对比剂是安全的。
- CTA空间分辨率优良,适合评估远端小肾动脉分支及介入后支架内狭窄;常规血管造影是参考标准,现仅用于介入操作。
核心结论
- RVH由RAS激活肾素-血管紧张素系统引起,RAS可为内在性狭窄或外压性压迫;影像学在RVH的诊断评估、排除其他继发性高血压病因及评估并发症中起重要作用,治疗取决于病因,包括药物治疗联合手术或介入操作。
研究设计与样本
- 综述类文章,检索范围与纳入文献原文未报告;文章总结了RVH的病因、诊断评估触发条件及各影像学方法(肾US、MRA、CTA、常规血管造影)的应用。
关键影像表现/征象
- RAS可为内在性狭窄(动脉粥样硬化、纤维肌性发育不良、血管炎、夹层、血栓、动脉瘤、动静脉瘘、1型神经纤维瘤病或中主动脉综合征)或外压性压迫(腹膜后纤维化、肿瘤或包膜下血肿/积液)。
- 肾US可评估血流动力学显著的RAS(包括支架内)及肾实质。
- MRA通常在US后进行;肾功能减退患者可不用对比剂或用ferumoxytol,2组钆对比剂是安全的。
- CTA空间分辨率优良,适合评估远端小肾动脉分支及介入后支架内狭窄。
- 常规血管造影是参考标准,现仅用于介入操作。
诊断标准与关键数值
- 常规血管造影是RVH的参考标准。
- 肾US(多普勒为主)可用于评估血流动力学显著的RAS,包括支架内狭窄。
- CTA适合评估远端小肾动脉分支和介入后支架内狭窄。
临床应用与阅片要点
- RVH的诊断评估可由高血压患者高度怀疑或非侵入性影像偶然发现RAS触发。
- 肾功能减退时,肾US(多普勒为主)常用于RVH初始筛查。
- MRA通常在US后进行;肾功能减退患者可不用对比剂或用ferumoxytol,2组钆对比剂是安全的。
- 常规血管造影现仅用于介入操作,不作为单纯诊断手段。
- 影像学也用于排除其他继发性高血压病因和评估RVH并发症。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Renovascular hypertension (RVH) results from activation of the renin-angiotensin system by renal arterial stenosis (RAS). RAS can result from either intrinsic narrowing or extrinsic compression. Intrinsic narrowing may be caused by atherosclerosis, fibromuscular dysplasia, vasculitis, dissection, thrombus, aneurysm, arteriovenous fistula, neurofibromatosis type 1, or midaortic syndrome. Extrinsic compression can be from retroperitoneal fibrosis, neoplasm, or subcapsular hematoma or fluid. Diagnostic evaluation for RVH is triggered by either a high index of suspicion in a patient with hypertension or incidental detection of RAS at noninvasive imaging. Renal US, primarily with Doppler, is a common modality used for initial screening of RVH, especially when renal function is decreased. US can be used to evaluate hemodynamically significant RAS, including in stents, and also for parenchymal evaluation. MR angiography (MRA) is an excellent modality for RVH evaluation, typically used following US. In patients with decreased renal function, MRA can be performed without contrast material or with ferumoxytol, but group 2 gadolinium-based contrast agents are safe. CT angiography offers excellent spatial resolution that is ideal for the evaluation of distal small renal arterial branches and for assessment of in-stent stenosis following intervention. Conventional angiography is the reference standard, now reserved only for interventional procedures. Imaging also plays an important role in excluding other causes of secondary hypertension and evaluating complications of RVH. The management of RVH depends on the cause and involves a combination of medical treatment and surgical or interventional procedures. Interventional options include angioplasty, stent placement, and embolization. ©RSNA, 2025 Supplemental material is available for this article.
引用
- Gonzalez TV, Bookwalter C, Khandelwal A, et al. Imaging in Renovascular Hypertension: State of the Art. Radiographics. 2025. PMID: 41231712. doi:10.1148/rg.240211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。